The public Defense programme booklet identifies Nolan as the OCRP2011 Teal Innovator. His perspective reports ovarian-cancer cohort classification and describes hoped-for clinical benefits. This documents a public biomedical programme association; it establishes no classified UAP approach or access.
Selected Nolan perspective and programme context readMAPS uses expert-labelled protein-expression data to classify cells. The authors report strong results within datasets, while acknowledging leakage risk from splitting one patient’s CODEX image by cells. Performance falls across cohorts and competing methods sometimes do better. Nolan is a coauthor and supervisor; disclosed commercial interests, reporting differences and missing original materials accompany the findings.
Complete supplied article and supplement text read; original and tiny-label gapsA selected 2017 cross-sectional study compared 20 Ebola survivors with 187 contacts from the Kikwit outbreak community. Cognitive and psychological score associations do not establish persistent causal brain injury, clinical diagnoses or 22 years of longitudinal follow-up. Small samples, instrument limitations and inconsistent source values remain explicit. Nolan is a coauthor; no UAP programme is discussed.
Supplied article and supporting text read; original layouts unavailableBarlow, Nolan and colleagues examine spatial immune patterns in a small diabetes donor study. The paper and its public reviews retain limits on selection, marker interpretation and causal inference; this is background biomedical research with no UAP-exposure cohort.
Paper text, figures and reviews readA curated public selection. Source review describes what was read; it does not establish that a claim is true. Our research approach